Traditionally Used Anti-hepatitis Plants Species in Dakar District, Senegal

Viral etiologies especially viral hepatitis B remain an area of concern sub-Saharan Africa with a variable prevalence between countries. Ethnobotanical knowledge of medicinal plants used in the treatment of viral hepatitis, in particular, viral hepatitis B, was conducted in the District of Dakar (Senegal). Forty-two participants were surveyed, which included 18 herbalists, 19 Traditional medicine practitioners (TMPs)and 5 resource persons. Fifty-one plant species were documented from forty-seven genera and thirty families. The most frequently mentioned families were; Fabaceae (11 species); Meliaceae, (4 species); Rubiaceae and Combretaceae (3 species each); Annonnacaea, Malvaceae, Rutaceae and Asteraceae (2 species each). All other families were represented by a single species. The decoction was the most common method of préparation (66.66%). Leaves and trunk bark were the plant parts of the plant most used. The most commonly used species were: Tinospora bakis (85.71%), Gardiena ternifolia (73.8%), Calotropis procera (71.42%), Carica papaya (66.66%), Citrus aurantifolia (64.28%) and Cochlospermum tinctorium (61.9%). It is concluded that the hepatoprotective properties of these plants are certainly induced by chemical compounds that will have to be identified later through phytochemical research.

Download Full-text

Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030?

World Journal of Gastroenterology ◽

10.3748/wjg.v27.i36.6025 ◽

2021 ◽

Vol 27 (36) ◽

pp. 6025-6038

Author(s):

Edina Amponsah-Dacosta

Keyword(s):

Hepatocellular Carcinoma ◽

Hepatitis B Virus ◽

Virus Infection ◽

Hepatitis B ◽

Viral Hepatitis ◽

Sub Saharan Africa ◽

Hepatitis B Virus Infection ◽

B Virus ◽

Sub Saharan

Download Full-text

Screening for Chronic Infectious Diseases by Serology in Those Presenting with Malaria in London, United Kingdom

American Journal of Tropical Medicine and Hygiene ◽

10.4269/ajtmh.20-1217 ◽

2021 ◽

Author(s):

Alison Gowland ◽

Emma McGuire ◽

Anna L. Goodman

Keyword(s):

Hepatitis B ◽

Infectious Diseases ◽

Local Population ◽

Malaria Diagnosis ◽

Chronic Viral Hepatitis ◽

Sub Saharan Africa ◽

Chronic Infections ◽

Appropriate Treatment ◽

Viral Hepatitis B ◽

Sub Saharan

The United Kingdom’s cases of malaria infection are primarily acquired in sub-Saharan Africa, with the majority of infections presenting in London.1 When patients go to a hospital with malaria, there is a screening opportunity for other geographically associated chronic infections. We identified patients who were diagnosed with malaria after presenting to our emergency department in London over a 2-year period, to assess whether there may be clinical benefit in screening for chronic viral (hepatitis B, hepatitis C, HIV) or parasitic (schistosomiasis, strongyloidiasis) infection in this cohort. Over this period, 131 patients were diagnosed with malaria. Crude seropositivity rates for HIV, hepatitis B, and strongyloidiasis were higher than expected compared with local population estimates, 7 and 28 times higher for HIV and hepatitis B, respectively. Those patients with previously unidentified cases were offered appropriate treatment. These findings support the potential clinical and public health benefits of screening for other infectious diseases in the context of a malaria diagnosis.

Download Full-text

HIV and viral hepatitis co-infection in pregnancy: an epidemiological, clinical and diagnostic review

Brazilian Journal of Biological Sciences ◽

10.21472/bjbs.040813 ◽

2017 ◽

Vol 4 (8) ◽

pp. 345-354

Author(s):

Sávio Freire da Silva ◽

Roseane Mara Cardoso Lima Verde ◽

José Felipe Pinheiro do Nascimento Vieira ◽

Leonardo Ferreira Soares ◽

Matheus Hipólito do Nascimento ◽

...

Keyword(s):

Hepatitis C ◽

Hepatitis B ◽

Viral Hepatitis ◽

Vertical Transmission ◽

Health Professionals ◽

The United States ◽

Sub Saharan Africa ◽

Chronic Complications ◽

Increased Risk ◽

Sub Saharan

Even though the survival of the population infected with HIV has been increased due to the intensification of antiretroviral therapy, co-infection with hepatitis B or hepatitis C has attracted the attention of doctors and other health professionals regarding the increased incidence of chronic complications resulting from viral hepatitis in HIV-infected population, which differs from that with other opportunistic diseases. Women coinfected with these viruses have an increased risk of complications during pregnancy, and the vertical transmission of these infections cause significant morbidity and mortality among children. This study aimed to investigate the risks of co-infection with HIV, hepatitis B, and hepatitis C during pregnancy, through a literature review of the last ten years, using the databases LILACS, MEDLINE and SCIELO, which make up the Virtual Health Library. A total of 106 articles were found, by searching in these databases, 46 of which were pre-selected to be read in full, resulting in 15 approved articles. It was noted that most of the accepted studies were carried out in countries of sub-Saharan Africa and Europe, followed by Brazil and the United States. The presence of co-infections made the infection worse and led to disease progression, both in the mother and in the child, compared to infection with only one of these viruses. Therefore, early diagnosis and prevention and treatment are essential to reduce and prevent the vertical transmission of these viruses.

Download Full-text